Information Journal Paper
APA:
Copy. (2017). Retinal vascular development with 0. 312 mg intravitreal bevacizumab to treat severe posterior retinopathy of prematurity: A Longitudinal Fluorescein Angiographic Study. RETINA, 37(1), 97-111. SID. https://sid.ir/paper/732979/en
Vancouver:
Copy. Retinal vascular development with 0. 312 mg intravitreal bevacizumab to treat severe posterior retinopathy of prematurity: A Longitudinal Fluorescein Angiographic Study. RETINA[Internet]. 2017;37(1):97-111. Available from: https://sid.ir/paper/732979/en
IEEE:
Copy, “Retinal vascular development with 0. 312 mg intravitreal bevacizumab to treat severe posterior retinopathy of prematurity: A Longitudinal Fluorescein Angiographic Study,” RETINA, vol. 37, no. 1, pp. 97–111, 2017, [Online]. Available: https://sid.ir/paper/732979/en